Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

The authors say there has been a recent uptick in hosptial admissions from hypoglycemic events, and that a therapy to address this is needed. A review of 15 studies has found that insulin degludec, ...

Degludec vs glargine in type 2 diabetes Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes. Steven P. Marso, MD, from the ...

Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit ...

San Diego, CA - The new longer-acting diabetes drug insulin degludec (Novo Nordisk) improves long-term glycemic control with a lower rate of nocturnal hypoglycemia compared with insulin glargine ...

A combination treatment containing ultra-long-acting insulin degludec and insulin aspart enhanced glucose control and reduced the risk of hypoglycemia, while insulin degludec alone also allowed for ...

Once-weekly efsitora noninferior to once-daily degludec for decrease in mean glycated hemoglobin level. (HealthDay News) — Once-weekly efsitora is noninferior to once-daily degludec for reducing ...

Combined insulin degludec/liraglutide lowers blood glucose and promotes weight loss without causing excess hypoglycemia among adults with type 2 diabetes who are not well-controlled using insulin ...

The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics ...

Data presented today show more participants achieved greater treatment satisfaction when switching to once-weekly insulin icodec in ONWARDS 2 trial ‘Once-weekly insulin would be a remarkable step ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio PHILADELPHIA — Insulin degludec is as ...

This material is intended for UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the ...